Featured Event Apply to the first edition of AseBio-Merck Award "Advanced Therapies Startup Competition" Madrid España Del 12/09/2022 to 05/10/2022 Healthcare Advanced therapies ¡Deadline extended! You can apply until October 5th
Advanced Therapies Week 2026 San Diego Estados Unidos Del 09/01/2026 to 12/08/2026 Advanced therapies
Personalized Vaccines, CAR-T, and AI: The New Horizon of Cancer Research 24/09/2025 Healthcare Innovative drugs Personalized medicine Advanced therapies On World Cancer Research Day, the AECC Scientific Foundation reminds us that only through the joint commitment of... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
Personalized Vaccines, CAR-T, and AI: The New Horizon of Cancer Research 24/09/2025 Fundación Científica de la Asociación Española Contra el Cáncer Cancer research is advancing thanks to biotechnology, but it still faces challenges such as equitable access and the... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
Integra Therapeutics secures €10.7 million investment round to advance development of FiCA... 08/09/2025 Healthcare Advanced therapies Financing The investment combines funds from new investors like the EIC Fund (European Commission) and CDTI Innvierte (Government... Partners - Integra Therapeutics S.L.
BCN HEALTH publishes a study highlighting the substantial productivity losses associated w... 03/09/2025 Healthcare Access to innovation Advanced therapies BCN HEALTH has published the study “Economic consequences of premature mortality due to brain cancer in Spain: a human... Partners - BCN Health
ORYZON receives European Medicines Agency approval to initiate a Phase Ib study of iadadem... 25/08/2025 Healthcare Advanced therapies First iadademstat clinical trial in non-malignant hematological indications. Partners - Oryzon Genomics
Webinar “What is needed to progress ATMPs in Europe” Online Del 10/07/2025 13:30 to 10/07/2025 Healthcare Advanced therapies
Advanced techniques to study intracellular nanoparticle trafficking 26/06/2025 Healthcare Access to innovation Advanced therapies Dr María Navalón recently defended her doctoral thesis at IQS, in which she developed and perfected advanced microscopy... Partners - IQS
AbilityPharma’s IBRILATAZAR (ABTL0812) doubles overall survival in patients with squamous ... 05/06/2025 Healthcare Innovative drugs Advanced therapies These results support ibrilatazar as a potential backbone therapy for patients with one of the most common subtypes of... Partners - Ability Pharmaceuticals
